FDA
-
-
-
-
-
-
-
PolarityTE Announces $8.0 Million Registered Direct and Private Placement Offerings Priced At-The-Market Under Nasdaq Rules
-
-
-
-
-
-
-
PolarityTE to Report Q1 2021 Financial Results on May 16, 2022
-
-
-
-
-
-
-
PolarityTE to Report Fiscal Year 2021 Financial Results on March 30, 2022
-
-
-
-
-
-
-
POLARITYTE DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against PolarityTE, Inc. and Encourages Investors to Contact the Firm
-
-
-
-
-
-
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against PolarityTE, Nano-X, and Eargo and Encourages Investors to Contact the Firm
-
-
-
-
-
-
-
PolarityTE Appoints Richard Hague as Chief Executive Officer and Elects David Seaburg to Board of Directors and Chair of Strategic Review Committee
-
-
-
-
-
-
-
SkinTEĀ® Met Primary and Secondary Endpoints in Final Analysis from Diabetic Foot Ulcer Trial
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

